In-depth valuation analysis including DCF scenarios and peer comparisons.
AI Insight: Acushnet’s current price exceeds the PERT-weighted fair value by 5.6%, suggesting slight overvaluation amid diverse valuation methods. High profitability and liquidity contrast with weak growth and moderate leverage, increasing risk. Monte Carlo analysis shows substantial downside risk (77.8%) and wide valuation volatility, indicating notable price uncertainty.